Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 3/2001

01-04-2001 | Conference Report

CK-19 Expression by RT-PCR in the Peripheral Blood of Breast Cancer Patients Correlates with Response to Chemotherapy

Authors: Ana Rita Manhani, Reinaldo Manhani, Heloisa P. Soares, Israel Bendit, Fabiana Lopes, André G.B. Nicoletti, Fernando L.A. Fonseca, Mafalda Novaes, Simone M. Zatta, Vitor Arias, Sergioi Giralt, Auro del Giglio

Published in: Breast Cancer Research and Treatment | Issue 3/2001

Login to get access
Metadata
Title
CK-19 Expression by RT-PCR in the Peripheral Blood of Breast Cancer Patients Correlates with Response to Chemotherapy
Authors
Ana Rita Manhani
Reinaldo Manhani
Heloisa P. Soares
Israel Bendit
Fabiana Lopes
André G.B. Nicoletti
Fernando L.A. Fonseca
Mafalda Novaes
Simone M. Zatta
Vitor Arias
Sergioi Giralt
Auro del Giglio
Publication date
01-04-2001
Publisher
Kluwer Academic Publishers
Published in
Breast Cancer Research and Treatment / Issue 3/2001
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1023/A:1010621901102

Other articles of this Issue 3/2001

Breast Cancer Research and Treatment 3/2001 Go to the issue

Conference Report

Breast Cancer Survival and in Vitro Tumor Response in the Extreme Drug Resistance Assay

Conference Report

Expression of Growth Factors, Growth Factor Receptors and Apoptosis Related Proteins in Invasive Breast Cancer: Relation to Apoptotic Rate

Conference Report

Wild Type p73 Overexpression and High-Grade Malignancy in Breast Cancer

Conference Report

Metallothionein 1F mRNA Expression Correlates with Histological Grade in Breast Carcinoma

Conference Report

Differential Expression of the Early Lung Cancer Detection Marker, Heterogeneous Nuclear Ribonucleoprotein-A2/B1 (hnRNP-A2/B1) in Normal Breast and Neoplastic Breast Cancer

Authors Index

Authors index, Volume 66
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits